(SWBI) Smith & Wesson Brands - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8317541063
SWBI EPS (Earnings per Share)
SWBI Revenue
SWBI: Handguns, Rifles, Suppressors, Firearm Accessories, Manufacturing Services
Smith & Wesson Brands Inc, a 170-year-old iconic firearms manufacturer, operates in a multifaceted industry, producing a diverse range of products that cater to various customer segments, including law enforcement, military, and civilian markets. The companys extensive product portfolio encompasses handguns, long guns, and accessories, as well as manufacturing services for other businesses, leveraging its expertise in forging, machining, and custom plastic injection molding.
The companys brand portfolio, including Smith & Wesson, M&P, and Gemtech, is marketed through a multi-channel approach, comprising independent dealers, retailers, and direct-to-consumer sales, supported by targeted advertising campaigns across print, broadcast, and digital media. With a strong heritage dating back to 1852, Smith & Wesson has established itself as a prominent player in the global firearms industry, with a presence in the US and international markets.
Analyzing the provided
Forecasting SWBIs future performance, we can anticipate a potential rebound in the stock price, driven by the companys diversified product portfolio and its ability to cater to various customer segments. However, the ongoing decline in the stock price and the relatively high P/E ratio compared to its historical averages may indicate a cautious outlook. Using the provided technical indicators, a potential buy signal could be generated if the stock price breaks above its SMA50 and SMA20, with a target price near $10.50. Conversely, a decline below the 52-week low of $8.48 could indicate further downside potential. A comprehensive analysis of the companys future earnings and industry trends would be necessary to make a more informed investment decision.
Additional Sources for SWBI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SWBI Stock Overview
Market Cap in USD | 479m |
Sector | Industrials |
Industry | Aerospace & Defense |
GiC Sub-Industry | Leisure Products |
IPO / Inception | 1998-11-09 |
SWBI Stock Ratings
Growth Rating | -47.9 |
Fundamental | -3.08 |
Dividend Rating | 77.9 |
Rel. Strength | -47.6 |
Analysts | 4.33 of 5 |
Fair Price Momentum | 7.90 USD |
Fair Price DCF | 7.70 USD |
SWBI Dividends
Dividend Yield 12m | 5.33% |
Yield on Cost 5y | 4.27% |
Annual Growth 5y | 38.52% |
Payout Consistency | 100.0% |
Payout Ratio | 1.7% |
SWBI Growth Ratios
Growth Correlation 3m | 52.3% |
Growth Correlation 12m | -88.2% |
Growth Correlation 5y | -56% |
CAGR 5y | -6.57% |
CAGR/Max DD 5y | -0.09 |
Sharpe Ratio 12m | -0.56 |
Alpha | -43.72 |
Beta | 0.416 |
Volatility | 39.91% |
Current Volume | 2403.6k |
Average Volume 20d | 384.6k |
As of June 24, 2025, the stock is trading at USD 8.69 with a total of 2,403,597 shares traded.
Over the past week, the price has changed by -18.76%, over one month by -7.61%, over three months by -8.87% and over the past year by -38.01%.
Neither. Based on ValueRay´s Fundamental Analyses, Smith & Wesson Brands is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -3.08 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SWBI is around 7.90 USD . This means that SWBI is currently overvalued and has a potential downside of -9.09%.
Smith & Wesson Brands has received a consensus analysts rating of 4.33. Therefor, it is recommend to buy SWBI.
- Strong Buy: 2
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, SWBI Smith & Wesson Brands will be worth about 8.6 in June 2026. The stock is currently trading at 8.69. This means that the stock has a potential downside of -1.38%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 13.8 | 59.1% |
Analysts Target Price | 13.8 | 59.1% |
ValueRay Target Price | 8.6 | -1.4% |